The company says its machine learning approach could help flag cardiac amyloidosis from standard 12-lead ECGs, though experts ...

HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored, ...

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...

Twelve-lead ECGs, although standard in hospitals, can be bulky and impractical for home use. On the other hand, Apple Watch’s ECG app is easy to use, but it is limited in what it can detect because it ...

HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT) ...

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful ...

Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed upon endpoints Company believes that labeling modifications can ...

HeartBeam (NASDAQ:BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG patch in approximately 50 patients with suspected coronary artery disease at two ...

(RTTNews) - HeartBeam, Inc. (BEAT), a medical technology company, announced Wednesday that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Company's groundbreaking ...

A systematic review and meta-analysis published in JAMA Internal Medicine identified persistent deficiencies in electrocardiogram interpretation across all levels of medical training. Analysis of 78 ...

Austin, Texas, May 26th, 2026, FinanceWireHeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how ...